THE ANABOLICPROTOCOL
SteroidsMedium risk

Testosterone

Also known as: Test, Test E, Test C, Test P, Testosterone Enanthate, Testosterone Cypionate, Testosterone Propionate, Testosterone Undecanoate, Testosteron, TRT, Nebido, Testoviron, Depo-Testosterone

The body's own base androgen and the foundation of practically every protocol — available in several esters that differ only in release rate, not in effect or risk profile.

Substance family

Testosterone derivatives

Built on the testosterone skeleton. Most convert to estradiol via aromatase, which is why estrogen management is a topic here — water retention, gynecomastia risk, and the option of an aromatase inhibitor.

Effects on

Which outcomes this substance acts on — descriptive, not a recommendation.

Strain profile

Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.

Liver
low
Kidneys
low
Blood lipids
medium
Hematocrit
high
Blood pressure
medium
Hormonal axis
high

Ester variants

Same active substance, same risk profile — only release rate and injection rhythm differ. The ester determines the timing, not the effect.

VariantHalf-lifeInjection interval
PropionateTest P, TestovironMost controllable, but the most injections and the most pronounced injection-site pain. Useful when the recovery phase has to start on a defined date.~0.8–2 daysEvery 1–2 days
EnanthateTest EThe most widely used base compound overall and the default choice in most regions.~4.5 days1–2× / week
CypionateTest C, Depo-TestosteroneThe default in North America. Differs from enanthate by a single carbon atom — the practical difference is negligible.~5–6 days1–2× / week
UndecanoateNebidoUsed almost exclusively in medical TRT. The very long interval makes dose adjustments slow and imprecise.~34 daysEvery 10–14 weeks
Blend of four estersSustanon 250, OmnadrenCombines short and long esters. Has its own page because the mixed release changes both level stability and exit planning.Mixed, ~1 to ~9 days1–2× / week

The ester also determines how long the substance stays active after the last injection — relevant when planning a recovery phase.

Dosing & protocols by goal

Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.

TRT / Substitution

Medical

Dose

100–200 mg / week

Frequency

1–2× / week

Cycle length

Ongoing (medically supervised)

The goal is to return to the physiological normal range, not above it. Splitting into two injections produces steadier levels than a single one.

Muscle building — Beginner

Beginner

Dose

300–500 mg / week

Frequency

1–2× / week

Cycle length

12–16 weeks

Often run as the sole base compound before adding further substances. A first cycle with testosterone alone shows how the body responds before more variables enter.

Mass building — Advanced

Advanced

Dose

≥ 500 mg / week (individual, open-ended)

Frequency

1–2× / week to daily

Cycle length

12–16+ weeks

Higher doses do not increase benefit linearly, but clearly raise risks and side effects — above all hematocrit and estradiol.

Base alongside other compounds

Advanced

Dose

250–500 mg / week

Frequency

1–2× / week

Cycle length

Duration of the cycle

Non-aromatizing compounds such as trenbolone or drostanolone provide no estrogen of their own — a testosterone base is what keeps estradiol functional.

Supraphysiological doses carry significant health risks and are not legal without a medical indication. This information serves education and harm reduction, not as a usage recommendation. Accompanying blood work and — where relevant — a post-cycle plan (PCT) are essential. See the disclaimer.

Side effect & countermeasure

Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.

Problem

Elevated hematocrit / thicker blood

Countermeasure

Regular cardio and adequate hydration; donate blood if strongly elevated. Monitor via blood work (hematocrit, hemoglobin). With long esters this develops slowly and is therefore often noticed late. Nattokinase supports fibrinolysis but does not lower the cell count — donation remains the measure that works.

Problem

Elevated blood pressure

Countermeasure

Cardio, watch salt and water balance, control weight. Medically, possibly telmisartan, amlodipine or lisinopril, and low-dose tadalafil.

Problem

Unfavorable lipid profile (HDL drops)

Countermeasure

Regular cardio, omega-3, possibly citrus bergamot; keep saturated fats moderate.

Problem

Aromatization → high estradiol (water, gyno risk)

Countermeasure

Use an aromatase inhibitor only when needed and lab-guided — do not 'blindly' crash estradiol. Anastrozole in the lowest effective dose; tamoxifen when breast tissue is already reacting.

Problem

Suppression of your own testosterone production (HPTA)

Countermeasure

Set a post-cycle / PCT plan before starting; the ester determines when it can begin. For TRT, ongoing medical supervision. HCG preserves testicular function during the cycle.

Problem

Peaks and troughs with infrequent injection

Countermeasure

A single weekly injection of a long ester produces noticeable swings in mood, libido and water retention. Splitting the same weekly dose into two injections evens this out at no extra cost.

Problem

Injection-site pain, especially with propionate

Countermeasure

Short esters irritate tissue more. Inject slowly, rotate sites systematically. Pain increasing after several days with redness and warmth indicates infection, not normal PIP — that needs a doctor.

Overview

Testosterone is the body's own principal androgen and the foundation of practically every protocol in this field. Medically it has been the gold standard for decades in treating diagnosed male hypogonadism; in the enhancement context it serves as the base compound on which everything else is built.

It is administered as an ester — testosterone itself would be broken down too quickly. The ester is an attached side chain that determines only how fast the hormone is released. That is the single most important thing to understand about the various preparations: enanthate, cypionate and propionate are the same hormone. What differs is the timing, not the effect and not the risk profile.

Mechanism of Action

Testosterone binds to the androgen receptor and thereby produces both anabolic (muscle-building) and androgenic (virilizing) effects. It is converted by the aromatase enzyme to estradiol and by 5-alpha-reductase to DHT — both metabolites have their own functions and their own side effects.

The ester itself is inactive. Only after enzymatic cleavage in the body does free testosterone become available. The length of the carbon chain determines how quickly that happens: propionate with three carbon atoms releases within days, undecanoate with eleven over weeks.

Estradiol deserves particular attention, because it is regularly misunderstood. Estrogen is not an unwanted by-product in the male body — it is needed for lipid metabolism, bone density, libido, joint comfort and mood. Too much causes water retention and gynecomastia risk; too little causes dry joints, low libido and flat mood. Both directions are a problem, which is why an aromatase inhibitor belongs in a protocol only when measurements justify it.

Choosing an Ester

The ester determines three practical things: how often you inject, how quickly a dose change takes effect, and how long the substance keeps working after the last injection.

For medical TRT and most cycles, enanthate or cypionate are the sensible default — one to two injections a week, stable levels, uncomplicated. Propionate is chosen when controllability matters: a first cycle, the final weeks of a preparation phase, or a recovery phase that has to start on a defined date.

Undecanoate is an outlier. With a half-life of over a month it is convenient in medical use but almost unusable for anything requiring adjustment — a dose change takes months to fully take effect.

What genuinely matters more than the choice of ester is the injection interval. A single weekly injection produces a pronounced peak in the first days and a corresponding trough before the next. Splitting the same weekly dose across two injections removes most of that swing without changing the total. It is the most effective adjustment available, and it costs nothing.

Typical Context

At supraphysiological doses — well above what the body produces naturally — testosterone is used to increase muscle mass and strength. In medical TRT, by contrast, doses are chosen that merely return the natural level to the normal range. These two use cases differ considerably in objective, dose height and risk profile; information about one cannot be transferred uncritically to the other.

As a base alongside other compounds, testosterone has a function beyond its own effect. Substances such as trenbolone, drostanolone or stanozolol do not aromatize and provide no estrogen of their own. Run without a testosterone base, they leave the body with no functioning estradiol level at all — which is why they are practically always combined with one.

Side Effects & Risks

  • Suppression of the body's own testosterone production (HPTA axis) — even at therapeutic doses
  • Aromatization to estradiol → possible water retention, gynecomastia risk
  • Increase in hematocrit/hemoglobin (thickening of the blood)
  • Shift in the lipid profile (tends to lower HDL)
  • Elevated blood pressure
  • Acne, accelerated hair loss with corresponding genetic predisposition
  • Injection-site pain, particularly with short esters
  • With improper injection technique: local infections, abscesses, nerve damage

Blood Work & Monitoring

Regular blood work is mandatory with any form of testosterone use, not optional. With long esters, draw at the trough — immediately before the next injection — and always at the same point, so values stay comparable.

  • Total/free testosterone — trough level before the next injection
  • Estradiol (sensitive) — to assess aromatization; watch both directions
  • Hematocrit & hemoglobin — checking for polycythemia
  • Liver values (ALT, AST, GGT)
  • Lipid profile (LDL, HDL, triglycerides)
  • Blood pressure — measured at home
  • PSA (from the appropriate age, for prostate monitoring)

Harm-Reduction Notes

  • Split the weekly dose across two injections — the simplest improvement to level stability
  • Allow four to five half-lives before judging blood work; before that, levels are still climbing
  • Do not crash estradiol; too low is as much a problem as too high
  • Use exclusively under medical supervision and with regular lab monitoring
  • Sterile single-use syringes and needles, no reuse, correct rotation of injection sites
  • The origin of the product is a central risk: counterfeits and underdosing are common on the black market
  • A post-cycle plan should be in place before starting — the ester determines when it can begin

Legal status by region

Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.

RegionRegulatory status
United StatesSchedule III controlled substancePrescription required; possession without one is a federal offence.
EU / UKPrescription-only medicineApproved for defined medical indications; supply without prescription is an offence.
Canada / AustraliaControlled substance, prescription-onlyImport for personal use is restricted.
Parts of Asia & Latin AmericaPharmacy availability variesSome countries treat it as pharmacy-dispensed rather than strictly prescription-bound. Enforcement is inconsistent and rules change.
Competitive sportProhibited at all timesListed by WADA; national anti-doping law applies in addition.
All content on this page is for information and harm-reduction purposes only. It is not medical advice, not a recommendation to purchase or use, and does not replace consulting a doctor. Legal status and enforcement vary by country and change; verifying the current rules in your own jurisdiction is your responsibility. For adults 18+ only. See the full disclaimer.